...
机译:Regorafenib, an investigational agent for the treatment of cholangiocarcinoma
H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA;
Cholangiocarcinoma; biliary tumors; regorafenib; FGFR2; actionable genes; TKIs; targeted therapy;